HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CMPS

Compass Pathways Plc ADR

Last Close
Jun 16 • 09:41AM ET
4.44
Dollar change
+0.05
Percentage change
1.14 		%
Healthcare • Medical Care Facilities • United Kingdom • NASD
Peers: MNMD ATAI CYBN GHRS RLMD AXSM MNOV XENE PRTA TVRD
 | Held by: ARKG IBB PSIL SBIO BBC GWX IBBQ BIB
Scroll to Statements
Index- P/E- EPS (ttm)-1.95 Insider Own9.34% Shs Outstand92.85M Perf Week-4.93%
Market Cap412.25M Forward P/E- EPS next Y-1.40 Insider Trans0.00% Shs Float84.17M Perf Month12.41%
Income-137.90M PEG- EPS next Q-0.42 Inst Own46.42% Short Float5.74% Perf Quarter28.32%
Sales0.00M P/S- EPS this Y35.09% Inst Trans126.63% Short Ratio4.18 Perf Half Y-1.99%
Book/sh2.11 P/B2.11 EPS next Y6.45% ROA-43.91% Short Interest4.84M Perf Year-35.09%
Cash/sh2.81 P/C1.58 EPS next 5Y17.08% ROE-60.67% 52W Range2.49 - 8.54 Perf YTD17.46%
Dividend Est.- P/FCF- EPS past 5Y- ROIC-63.47% 52W High-47.99% Beta2.25
Dividend TTM- Quick Ratio10.18 Sales past 5Y- Gross Margin- 52W Low78.31% ATR (14)0.34
Dividend Ex-Date- Current Ratio10.18 EPS Y/Y TTM17.52% Oper. Margin- RSI (14)54.25 Volatility2.46% 4.04%
Employees166 Debt/Eq0.16 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price17.30
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q63.28% Payout- Rel Volume0.63 Prev Close4.39
Sales Surprise- EPS Surprise48.62% Sales Q/Q- EarningsMay 08 BMO Avg Volume1.16M Price4.44
SMA20-0.03% SMA5014.02% SMA200-3.51% Trades Volume56,182 Change1.14%
Date Action Analyst Rating Change Price Target Change
Feb-27-25Initiated Stifel Buy $11
Jul-23-24Initiated RBC Capital Mkts Outperform $23
Apr-01-24Initiated Morgan Stanley Overweight $30
Dec-12-23Initiated Deutsche Bank Buy $16
Nov-21-22Resumed Berenberg Buy $33
Nov-01-22Initiated Loop Capital Buy $34
Oct-29-21Initiated Oppenheimer Outperform $50
Jul-13-21Initiated Citigroup Buy $67
Jun-28-21Initiated Maxim Group Buy $70
May-11-21Initiated Cantor Fitzgerald Overweight $71
Show Previous Ratings
May-14-25 12:00PM
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know
(Zacks)
06:30AM
Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
(Business Wire)
May-09-25 11:11AM
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
(TipRanks)
03:12AM
Compass Pathways PLC (CMPS) Q1 2025 Earnings Call Highlights: Pivotal Phase 3 Trial Milestone ...
(GuruFocus.com)
May-08-25 06:30AM
Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
(Business Wire)
06:00PM Loading…
May-07-25 06:00PM
Here are the major earnings before the open tomorrow
(Seeking Alpha)
12:34PM
COMPASS Pathways ADS Q1 2025 Earnings Preview
(Seeking Alpha)
Apr-29-25 06:30AM
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
(Business Wire)
Apr-28-25 06:30AM
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
(Business Wire)
Apr-27-25 03:31PM
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
(Market Exclusive)
Apr-25-25 06:13PM
Why Compass Pathways Stock Was a Double-Digit Winner This Week
(Motley Fool)
11:30AM
Psychedelic: Clearmind completes clinical site initiations for AUD trial
(TipRanks)
Apr-22-25 06:00AM
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
(Business Wire) +5.62%
Mar-28-25 05:01PM
This Is a Test From GlobeNewswire
(GlobeNewswire)
Mar-26-25 06:30AM
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
(Business Wire)
10:30AM Loading…
Mar-22-25 10:30AM
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
(TipRanks)
Mar-21-25 11:50AM
Psychedelic: atai Life Sciences, NRx report quarterly results
(TipRanks)
Mar-20-25 11:15AM
Lazard International Strategic Equity Portfolio Q4 2024 Commentary
(SeekingAlpha)
05:35AM
Lazard International Equity Select Portfolio Q4 2024 Commentary
(SeekingAlpha)
Mar-18-25 06:30AM
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
(Business Wire) -6.94%
Mar-11-25 06:30AM
Compass Pathways to Participate in Stifel Virtual CNS Forum
(Business Wire)
Mar-05-25 11:06AM
Compass one of the most compelling stories in neuropsych, says H.C. Wainwright
(TipRanks)
Mar-01-25 11:15AM
COMPASS Pathways plc (CMPS): Among the Best Psychedelic Stocks to Buy in 2025
(Insider Monkey)
Feb-28-25 11:30AM
Psychedelic: GH Research, Compass Pathways report earnings results
(TipRanks)
02:11AM
Compass Pathways PLC (CMPS) Q4 2024 Earnings Call Highlights: Strategic Financing and R&D ...
(GuruFocus.com)
Feb-27-25 03:15PM
Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript
(Motley Fool) +5.95%
06:30AM
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
(Business Wire)
Feb-25-25 04:00PM
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
(Business Wire)
Feb-18-25 06:30AM
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
(Business Wire)
Feb-13-25 04:14PM
It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care
(Investor's Business Daily)
01:25PM Loading…
Feb-12-25 01:25PM
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
(Investor's Business Daily)
Feb-05-25 06:30AM
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
(Business Wire) +5.50%
Jan-21-25 06:30AM
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
(Business Wire)
Jan-10-25 07:01AM
Compass Pathways Announces Pricing of Underwritten Offering
(Business Wire) -14.73%
Dec-18-24 06:30AM
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
(Business Wire) -6.43%
Nov-29-24 08:57PM
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
(Motley Fool)
Nov-25-24 04:00PM
Compass Pathways to Participate in December Investor Conferences
(Business Wire)
Nov-14-24 07:44AM
Compass Pathways to participate in Stifel 2024 Healthcare Conference
(GlobeNewswire)
Nov-02-24 09:25AM
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
(TipRanks)
Nov-01-24 11:00AM
Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
(GuruFocus.com)
Oct-31-24 09:00PM
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
(Motley Fool) -23.10%
08:03AM
Compass delays anticipated psilocybin readout, cuts staff
(BioPharma Dive)
06:30AM
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
(Business Wire)
Oct-24-24 06:30AM
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
(Business Wire)
Sep-23-24 07:00AM
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
(Business Wire)
Aug-28-24 06:00AM
Compass Pathways to participate in three investor conferences in September
(GlobeNewswire)
Aug-25-24 09:06AM
Morgan Stanley Predicts up to 220% Jump for These 2 Strong Buy Stocks
(TipRanks)
Aug-19-24 07:13AM
More promise for psilocybin in depression but safety remains a concern
(Clinical Trials Arena)
Aug-12-24 12:47PM
FDA Rejection of MDMA Therapy Isnt End of Psychedelic-Drug Candidates
(Barrons.com)
Aug-06-24 08:00AM
COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference
(GlobeNewswire)
Aug-01-24 11:30PM
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript
(Motley Fool) -9.83%
06:30AM
Compass Pathways announces second quarter 2024 financial results and business highlights
(GlobeNewswire)
Jul-28-24 06:05PM
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
(Market Exclusive)
Jul-24-24 07:01AM
Compass Pathways to announce second quarter financial results on August 1, 2024
(GlobeNewswire)
Jul-11-24 07:00AM
3 Dirt-Cheap Drug Developers With Blockbuster Potential
(InvestorPlace) +9.39%
Jul-08-24 07:45AM
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
(InvestorPlace)
Jul-02-24 03:43PM
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
(InvestorPlace)
Jun-26-24 06:30AM
Compass Pathways appoints Lori Englebert as Chief Commercial Officer
(GlobeNewswire)
Jun-24-24 04:01PM
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
(GlobeNewswire)
Jun-12-24 06:25AM
Should You Buy the Dip on Compass Pathways Stock?
(Motley Fool) +7.04%
Jun-10-24 08:25AM
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
(Motley Fool) -5.62%
Jun-09-24 06:14PM
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
(Washington Post)
Jun-05-24 11:42AM
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
(The Wall Street Journal)
May-21-24 08:05AM
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
(Motley Fool)
May-13-24 10:43AM
COMPASS Pathways plc (NASDAQ:CMPS) Q1 2024 Earnings Call Transcript
(Insider Monkey)
May-09-24 04:45AM
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
(Motley Fool)
May-08-24 06:45AM
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
(GlobeNewswire)
06:30AM
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
(GlobeNewswire)
May-03-24 04:58PM
Compass Pathways to announce first quarter financial results on May 8, 2024
(GlobeNewswire)
May-02-24 06:30AM
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
(GlobeNewswire)
Apr-29-24 06:30AM
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
(GlobeNewswire)
Apr-01-24 04:01PM
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
(GlobeNewswire) +16.35%
Mar-31-24 05:47PM
20 Most Depressed Countries in Asia
(Insider Monkey)
Mar-28-24 08:00AM
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
(GlobeNewswire) -12.42%
Mar-19-24 08:00AM
The Next Great Biotech Boom Has Arrived
(PR Newswire)
Mar-10-24 10:00AM
10 Alternatives to Antidepressant Medications
(Insider Monkey)
Mar-05-24 09:59AM
15 Highest Paying Jobs with a Psychology Degree
(Insider Monkey) -5.48%
08:52AM
20 Countries with Most Antidepressant Users in the World
(Insider Monkey)
Mar-01-24 09:08AM
COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript
(Insider Monkey) +11.78%
Feb-29-24 03:30PM
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript
(Motley Fool) -16.98%
07:34AM
Compass Pathways PLC Reports Increased Annual Net Loss Amid Clinical Advancements
(GuruFocus.com)
07:00AM
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights
(GlobeNewswire)
Feb-27-24 12:33PM
Penny Power Players: 3 Stocks to Watch in the Microcap Arena
(InvestorPlace) +9.64%
Feb-26-24 04:01PM
Compass Pathways to participate in upcoming TD Cowen investor conference
(GlobeNewswire)
Feb-22-24 04:01PM
Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
(GlobeNewswire)
Feb-21-24 03:06PM
Mental Health Mavericks: 3 Stocks Changing the Game
(InvestorPlace)
Feb-19-24 07:00AM
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
(Motley Fool)
Feb-02-24 04:27PM
As investors pile into psychedelics, idealism gives way to pharma economics
(Associated Press Finance)
Jan-31-24 04:01PM
Compass Pathways to participate in upcoming Oppenheimer investor conference
(GlobeNewswire)
Jan-24-24 09:00AM
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
(PR Newswire) +7.87%
Jan-16-24 08:00AM
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
(GlobeNewswire)
Jan-09-24 01:56PM
Therapys New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
(InvestorPlace)
Jan-08-24 11:47AM
3 Big New Catalysts for Psychedelics Stocks in 2024
(Motley Fool) +11.07%
Jan-05-24 08:00AM
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
(GlobeNewswire) -6.97%
Dec-29-23 08:42AM
5 Best Psychedelic Stocks to Buy
(Insider Monkey)
Dec-19-23 04:05PM
Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder
(GlobeNewswire) -5.87%
Dec-13-23 02:55PM
25 Best Online Psychology Degree Programs Heading Into 2024
(Insider Monkey) -6.62%
Dec-07-23 07:00AM
Compass Pathways appoints Teri Loxam as Chief Financial Officer
(GlobeNewswire) +7.94%
Dec-06-23 04:00PM
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
(GlobeNewswire)
Dec-05-23 04:09PM
Investing in Mental Health: 3 Stocks in the Wellness Space
(InvestorPlace) -7.38%
Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ATAI Life Sciences N.V.10% OwnerSep 26 '24Sale6.052,660,00016,093,0006,905,774Sep 27 08:00 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.